The Delhi High Court on Thursday reserved its verdict in over 450 petitions filed by drug and healthcare majors challenging the Centre?s decision to ban 344 fixed dose combination (FDC) medicines, including well known brands like Corex cough syrup, Vicks Action 500 extra and D?Cold.
After hearing arguments of the companies like Pfizer, Glenmark, Procter and Gamble and Cipla, the central government and some NGOs like All India Drug Action Network (AIDAN) over a span of over two months starting from March 14, Justice Rajiv Sahai Endlaw reserved judgement on the pleas questioning the Centre?s decision.
- See more at: http://indianexpress.com/article/india/india-news-india/delhi-hc-reserves-verdict-on-pleas-against-ban-on-344-drugs-2831173/#sthash.nrbNdhfL.dpuf
Read more: Click Here
The Ministry of Women and Child Development will celebrate the fifth Poshan Pakhwada from 20th March...
A new Global Oral Health Status Report published today by the World Health Organization (W...
Main Highlights: This is the second successful mega health camp to offer improved healthcare serv...
Union Ministry of Health & Family Welfare is organizing a two days conclave commemorating the &l...
9th World Ayurveda Congress (WAC) was inaugurated today at Panaji, Goa in the presence of Union Mini...